Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Myeloma Knowledge Exchange 2019 (MyKE Myeloma) /
Myeloma bone disease: Clinical features and complications

10th - 11th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.05.19
Views: 1106

Dr Andrew Chantry - University of Sheffield, Sheffield, UK

Dr Andrew Chantry speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about bone disease in multiple myeloma.

He describes the pathophysiology of this disease and the current treatments available to treat this; along with their disadvantages.

Dr Chantry also mentions the psychological effects this disease can cause and states how future efforts should focus on improving these, along with other aspects to improve patient outcomes.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation